Royalty Pharma (RPRX) Income - Equity (2019 - 2026)
Royalty Pharma's Income - Equity was $4.08 million in Q2 2026, up 51.4% from $2.69 million a year earlier but down 81.3% from the prior quarter.
Powered by 
Analysis
Royalty Pharma (RPRX) Income - Equity (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Royalty Pharma's Income - Equity was $45.79 million through Jun 30, 2026, down 10.6% year-over-year; for FY2025, it was $29.09 million, down 1.8% from FY2024.
- Income - Equity shows a five-year compound annual growth rate of -8.1% (FY2020 to FY2025).
- In earlier years, Income - Equity was $29.61 million in FY2024 (+2.5%), $28.88 million in FY2023, -$8.97 million in FY2022 and -$19.49 million in FY2021.
- Quarterly Income - Equity has moved between -$38.02 million (Q4 2021) and $34.61 million (Q1 2023) over five years.
- Compared with a year earlier, Income - Equity was higher in four of the last five quarters, with growth averaging 62.6%.
- Per Business Quant data, RPRX's Income - Equity in the three quarters before Q2 2026 was $21.76 million (Q1 2026), $4.01 million (Q4 2025) and $15.95 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income - Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Rocket Companies | 40.96 Bn | 29.78 Bn | - | - |
| 2 | Orix | 36.82 Bn | 3.63 Bn | - | - |
| 3 | Royalty Pharma | 30.51 Bn | 27.88 Bn | - | 9.23 Mn |
| 4 | Federal National Mortgage Association Fannie Mae | 26.64 Bn | 26.64 Bn | - | - |
| 5 | Royal Gold | 23.60 Bn | 22.77 Bn | 390.45 Mn | - |
| 6 | Synchrony Financial | 23.18 Bn | -44.45 Bn | - | - |
| 7 | Affirm Holdings | 23.17 Bn | 16.22 Bn | - | - |
| 8 | Annaly Capital Management | 14.38 Bn | 5.33 Bn | - | 12.81 Mn |
| 9 | Ares Capital | 13.91 Bn | 11.66 Bn | - | - |
| 10 | Federal Home Loan Mortgage | 12.97 Bn | -5.71 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 9.23 Mn |
| Jun 30, 2026 | 4.08 Mn |
| Mar 31, 2026 | 21.76 Mn |
| Dec 31, 2025 | 4.01 Mn |
| Sep 30, 2025 | 15.95 Mn |
| Jun 30, 2025 | 2.69 Mn |
| Mar 31, 2025 | 6.44 Mn |
| Dec 31, 2024 | 31.65 Mn |
| Sep 30, 2024 | 10.41 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Mar 31, 2024 | -14.15 Mn |
| Dec 31, 2023 | 268,000.00 |
| Sep 30, 2023 | -5.22 Mn |
| Jun 30, 2023 | -770,000.00 |
| Mar 31, 2023 | 34.61 Mn |
| Dec 31, 2022 | -6.86 Mn |
| Sep 30, 2022 | -3.25 Mn |
| Jun 30, 2022 | 737,000.00 |
| Mar 31, 2022 | 397,000.00 |
| Dec 31, 2021 | -38.02 Mn |
API Access
Royalty Pharma Income - Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-equity&ticker=RPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-equity", "ticker": "RPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-equity&ticker=RPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();